covid
Buscar en
Revista Médica Internacional sobre el Síndrome de Down (English Edition)
Toda la web
Inicio Revista Médica Internacional sobre el Síndrome de Down (English Edition) Ageing in Down Syndrome: DYRK1A As a Candidate Gene for Cognitive Decline
Información de la revista
Vol. 12. Núm. 3.
Páginas 34-40 (noviembre 2008)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 12. Núm. 3.
Páginas 34-40 (noviembre 2008)
Acceso a texto completo
Ageing in Down Syndrome: DYRK1A As a Candidate Gene for Cognitive Decline
Visitas
735
María Martínez de Lagrán1,2, Analía Bortolozzi3, Juan Gispert4, Olga Millán4, Francesc Artigas3, Cristina Fillat1,2, Maria del Mar Dierssen1,2,
Autor para correspondencia
mara.dierssen@crg.es

Correspondence.
1 Programa Genes y Enfermedad, Centro de Regulación Genomica, (CRG-UPF) PRBB, Barcelona, Spain
2 Centro de Investigación Biomédica en Red Enfermedades Raras (CIBERER), Barcelona, Spain
3 Departmento de Neuroquímica, Institut d’Investigacions Biomediques de Barcelona (CSIC), IDIBAPS, Barcelona, Spain
4 Departamento de Imagen Animal, Institut d’Alta Tecnologia (IAT-CRC Corporació Sanitaria), PRBB, Barcelona, Spain
Este artículo ha recibido
Información del artículo
Abstract

The DYRK1A gene has been implicated in the degenerative process observed in Down syndrome; however, its precise role and pathogenetic mechanisms are still unclear. This paper reviews experimental work conducted in genetically modified mice with differing doses of the gene. The results suggest that DYRK1A is a dosesensitive gene that may participate in motor and cognitive disturbances and in Alzheimer-like neuropathologic processes in persons with Down syndrome, according to the gene's expression pattern and the phosphorylation substrates identified.

Keywords:
Aneuploidy
Dose-sensitive genes
Motor skills disorders
Dopaminergic System
El Texto completo está disponible en PDF
Bibliography
[1.]
C. Oliver, L. Crayton, et al.
A four year prospective study of age-related cognitive change in adults with Down's syndrome.
Psychol Med, 28 (1998), pp. 1365-1377
[2.]
J. Shultz, M. Aman, et al.
Evaluation of screening tools for dementia in older adults with mental retardation.
[3.]
M. Dierssen, M. Martínez de Lagran.
DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) : a gene with dosage effect during development and neurogenesis.
Scientific World Journal, 6 (2006), pp. 1911-1922
[4.]
M. Cuskelly, A. Jobling, et al.
Down syndrome across the life span.
Whurr, (2002),
[5.]
L. Nadel.
Down's syndrome: a genetic disorder in biobehavioral perspective.
Genes Brain Behav, 2 (2003), pp. 156-166
[6.]
J. Vázquez.
Educación física de base y actividades lúdicas.
Síndrome de Down y educación,
[7.]
U. Frith, C.D. Frith.
Specific motor disabilities in Down's syndrome.
J Child Psychol Psychiatry, 15 (1974), pp. 293-301
[8.]
X. Altafaj, M. Dierssen, et al.
Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.
Hum Mol Genet, 10 (2001), pp. 1915-1923
[9.]
A.W. Parker, R. Bronks, et al.
Walking patterns in Down's syndrome.
J Ment Defic Res, 30 (1986), pp. 317-330
[10.]
M. Kubo, B. Ulrich.
Coordination of pelvis-HAT (head, arms and trunk) in anterior-posterior and medio- lateral directions during treadmill gait in preadolescents with/without Down syndrome.
Gait Posture, 23 (2006), pp. 512-518
[11.]
T.G. Hampton, M.R. Stasko, et al.
Gait dynamics in trisomic mice: quantitative neurological traits of Down syndrome.
Physiol Behav, 82 (2004), pp. 381-389
[12.]
I. Branchi, Z. Bichler, et al.
Transgenic mouse in vivo library of human Down syndrome critical region 1: association between DYRK1A overexpression, brain development abnormalities, and cell cycle protein alteration.
J Neuropathol Exp Neurol, 63 (2004), pp. 429-440
[13.]
R.M. Escorihuela, A. Fernández-Teruel, et al.
A behavioral assessment of Ts65Dn mice: a putative Down syndrome model.
Neurosci Lett, 199 (1995), pp. 143-146
[14.]
H. Sago, E.J. Carlson, et al.
Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome.
Pediatr Res, 48 (2000), pp. 606-613
[15.]
A. Inoue, Y. Nakata.
Strategy for modulation of central dopamine transmission based on the partial agonist concept in schizophrenia therapy.
Jpn J Pharmacol, 86 (2001), pp. 376-380
[16.]
S. Vicari.
Motor development and neuropsychological patterns in persons with Down syndrome.
Behav Genet, 36 (2006), pp. 355-364
[17.]
C. Jarrold, A.D. Baddeley.
Short-term memory in Down syndrome: applying the working memory model.
Downs Syndr Res Pract, 7 (2001), pp. 17-23
[18.]
P.L. Roubertoux, Z. Bichler, et al.
Pre-weaning Sensorial and Motor Development in Mice Transpolygenic for the Critical Region of Trisomy 21.
Behav Genet, 36 (2006), pp. 377-386
[19.]
L. Nelson, J.K. Johnson, et al.
Learning and memory as a function of age in Down syndrome: a study using animal-based tasks.
Prog Neuropsychopharmacol Biol Psychiatry, 29 (2005), pp. 443-453

Work awarded the 2nd Ramon Trias Fargas Award for Research on Down Syndrome.

Copyright © 2008. Fundació Catalana Síndrome Down
Descargar PDF
Opciones de artículo